类风湿关节炎研究进展3.pptVIP

  • 7
  • 0
  • 约3.71万字
  • 约 145页
  • 2018-05-28 发布于浙江
  • 举报
* * 用药期间不宜采用活疫苗 * * Although the numbers of subjects treated are small, there is a strong trend suggesting increased mortality in CHF patients treated with Infliximab. * * CDP870是由一个与聚乙二醇相连的靶向TNF的人源化Fab抗体片段构成的,其在体内的半衰期延长,给药次数减少。 * * * * * * Kineret? mimics endogenous IL-1Ra to help compensate for cytokine imbalance and control symptoms. * * Anakinra is somewhat less effective than etanercept and infliximab in reducing clinical symptoms and signs of active RA. * * IL-1 trap: receptor 1, IL-1RAcP; receptor 2, IL-1RI. * * * * * * * * In this double-blind, randomised, placebo-controlled,

文档评论(0)

1亿VIP精品文档

相关文档